Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

Lamora, A., Mullard, M., Amiaud, J. et al. (4 more authors) (2015) Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. Oncotarget, 6 (16). pp. 14413-14427. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2015 Impact Journals. All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Keywords: halofuginone; osteosarcoma; TGF-beta; metastases; bone remodeling
Dates:
  • Published: 7 May 2015
  • Accepted: 24 April 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 13 Apr 2016 08:24
Last Modified: 30 Aug 2019 13:22
Published Version: http://dx.doi.org/10.18632/oncotarget.3891
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.3891
Related URLs:

Share / Export

Statistics